Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Jul;37(1):132–135. doi: 10.1136/gut.37.1.132

Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

P Desreumaux 1, A Janin 1, E Delaporte 1, S Dubucquoi 1, F Piette 1, A Cortot 1, M Capron 1, J F Colombel 1
PMCID: PMC1382784  PMID: 7672663

Abstract

A 59 year old man is presented with a diagnosis of dermatitis herpetiformis. Duodenal and skin biopsy specimens from blisters of both recent and late onset were collected before treatment. Electron microscopy, immunohistochemistry, and in situ hybridisation were performed to analyse the presence of activated eosinophils and the local synthesis of interleukin 5 (IL5). Parallel state of eosinophil activation and IL5 synthesis was found in the duodenal mucosa with total flat mucosa and in skin vesicles of recent onset. It is suggested that duodenal and cutaneous eosinophils can synthesise IL5 and then participate in small bowel and skin lesions.

Full text

PDF
132

Images in this article

133Figure 1
on p.133
134Figure 2
on p.134
134Figure 3
on p.134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blenkinsopp W. K., Haffenden G. P., Fry L., Leonard J. N. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol. 1983 Dec;5(6):547–554. doi: 10.1097/00000372-198312000-00005. [DOI] [PubMed] [Google Scholar]
  2. Capron M., Tomassini M., Van der Vorst E., Kusnierz J. P., Papin J. P., Capron A. Existence et fonctions d'un récepteur pour l'immunoglobuline A sur les éosinophiles humains. C R Acad Sci III. 1988;307(7):397–402. [PubMed] [Google Scholar]
  3. Chihara J., Plumas J., Gruart V., Tavernier J., Prin L., Capron A., Capron M. Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med. 1990 Nov 1;172(5):1347–1351. doi: 10.1084/jem.172.5.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colombel J. F., Torpier G., Janin A., Klein O., Cortot A., Capron M. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut. 1992 Sep;33(9):1190–1194. doi: 10.1136/gut.33.9.1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Desreumaux P., Janin A., Colombel J. F., Prin L., Plumas J., Emilie D., Torpier G., Capron A., Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992 Jan 1;175(1):293–296. doi: 10.1084/jem.175.1.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dubucquoi S., Desreumaux P., Janin A., Klein O., Goldman M., Tavernier J., Capron A., Capron M. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med. 1994 Feb 1;179(2):703–708. doi: 10.1084/jem.179.2.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Graeber M., Baker B. S., Garioch J. J., Valdimarsson H., Leonard J. N., Fry L. The role of cytokines in the generation of skin lesions in dermatitis herpetiformis. Br J Dermatol. 1993 Nov;129(5):530–532. doi: 10.1111/j.1365-2133.1993.tb00479.x. [DOI] [PubMed] [Google Scholar]
  8. Jalkanen S., Saari S., Kalimo H., Lammintausta K., Vainio E., Leino R., Duijvestijn A. M., Kalimo K. Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J Invest Dermatol. 1990 Jun;94(6):786–792. doi: 10.1111/1523-1747.ep12874646. [DOI] [PubMed] [Google Scholar]
  9. Katz S. I. Dermatitis herpetiformis. Clinical, histologic, therapeutic and laboratory clues. Int J Dermatol. 1978 Sep;17(7):529–535. doi: 10.1111/j.1365-4362.1978.tb05996.x. [DOI] [PubMed] [Google Scholar]
  10. Katz S. I., Hall R. P., 3rd, Lawley T. J., Strober W. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med. 1980 Dec;93(6):857–874. doi: 10.7326/0003-4819-93-6-857. [DOI] [PubMed] [Google Scholar]
  11. Ljunghall K., Tjernlund U. Dermatitis herpetiformis: effect of gluten-restricted and gluten-free diet on dapsone requirement and on IgA and C3 deposits in uninvolved skin. Acta Derm Venereol. 1983;63(2):129–136. [PubMed] [Google Scholar]
  12. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988 Jan 1;167(1):219–224. doi: 10.1084/jem.167.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marsh M. N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 1992 Jan;102(1):330–354. [PubMed] [Google Scholar]
  14. Marsh M. N., Hinde J. Inflammatory component of celiac sprue mucosa. I. Mast cells, basophils, and eosinophils. Gastroenterology. 1985 Jul;89(1):92–101. doi: 10.1016/0016-5085(85)90749-8. [DOI] [PubMed] [Google Scholar]
  15. Monteiro R. C., Hostoffer R. W., Cooper M. D., Bonner J. R., Gartland G. L., Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest. 1993 Oct;92(4):1681–1685. doi: 10.1172/JCI116754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Maillot M. C., Lemaigre G., Galanaud P. IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol. 1990 Feb;136(2):383–390. [PMC free article] [PubMed] [Google Scholar]
  17. Salmi M., Jalkanen S. Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am. 1991 Sep;20(3):495–510. [PubMed] [Google Scholar]
  18. Wong D. T., Weller P. F., Galli S. J., Elovic A., Rand T. H., Gallagher G. T., Chiang T., Chou M. Y., Matossian K., McBride J. Human eosinophils express transforming growth factor alpha. J Exp Med. 1990 Sep 1;172(3):673–681. doi: 10.1084/jem.172.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med. 1988 May 1;167(5):1737–1742. doi: 10.1084/jem.167.5.1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med. 1988 Jan 1;167(1):43–56. doi: 10.1084/jem.167.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES